Ameritas Advisory Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$400K Buy
6,189
+535
+9% +$37.7K 0.02% 660
2025
Q4
$381K Buy
+5,654
New +$380K 0.01% 669

Other funds holding HALO

Ameritas Advisory Services's HALO Position: Q1 2026 in Review

Ameritas Advisory Services increased its Halozyme (HALO) stake by 9.5% in Q1 2026, buying an estimated $37.7K and bringing the position to 6,189 shares worth $400K. The position accounts for 0.02% of the portfolio, ranked #660.

Ameritas Advisory Services first reported a position in HALO in Q4 2025 and has held it in 2 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Ameritas Advisory Services held 6,189 shares of Halozyme worth $400K as of Q1 2026.
  • Ameritas Advisory Services bought 535 Halozyme shares in Q1 2026, an estimated $37.7K.
  • Halozyme made up 0.02% of Ameritas Advisory Services's portfolio in Q1 2026, its #660 holding.
  • Ameritas Advisory Services first reported a position in Halozyme in Q4 2025 and has held it in 2 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.